SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Craig Tengler who wrote (579)5/21/1998 5:06:00 PM
From: Bajasurfer  Read Replies (1) of 1754
 
I'm a publisher of eye care brochures, cd roms, posters, etc. As such I'm very aware of VISX.

I believe this company is extremely undervalued. Let me make my argument:

VISX owns the patents on most of the laser vision correction procedures. VISX receives royalty payments from their competitors.

A client of mine has performed over 6,000 Lasik procedures over the last two years. I have heard that VISX receives $250 per procedure for a royalty (can someone please confirm the $250) This translates into 1.5 million dollars.

Therein is the real value of VISX. Patented technology that everyone needs.

I really believe this stock can hit $100.00 in the next year!

Robert
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext